BEAM logo

Beam Therapeutics (BEAM) Selling, general & administrative expenses

annual SGA:

$111.53M-$5.29M(-4.53%)
December 31, 2024

Summary

  • As of today (July 1, 2025), BEAM annual SGA is $111.53 million, with the most recent change of -$5.29 million (-4.53%) on December 31, 2024.
  • During the last 3 years, BEAM annual SGA has risen by +$54.30 million (+94.90%).
  • BEAM annual SGA is now -4.53% below its all-time high of $116.81 million, reached on December 31, 2023.

Performance

BEAM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

quarterly SGA:

$27.94M-$720.00K(-2.51%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BEAM quarterly SGA is $27.94 million, with the most recent change of -$720.00 thousand (-2.51%) on March 31, 2025.
  • Over the past year, BEAM quarterly SGA has increased by +$1.22 million (+4.55%).
  • BEAM quarterly SGA is now -35.41% below its all-time high of $43.26 million, reached on December 31, 2023.

Performance

BEAM quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

TTM SGA:

-$6.10B-$387.34M(-6.78%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BEAM TTM SGA is -$6.10 billion, with the most recent change of -$387.34 million (-6.78%) on March 31, 2025.
  • Over the past year, BEAM TTM SGA has dropped by -$6.22 billion (-5180.03%).
  • BEAM TTM SGA is now -4789.77% below its all-time high of -$124.72 million.

Performance

BEAM TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

BEAM Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-4.5%+4.5%-5180.0%
3 y3 years+94.9%+45.2%-9312.7%
5 y5 years+442.6%+310.2%-10000.0%

BEAM Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-4.5%+94.9%-35.4%+28.1%-89.5%at low
5 y5-year-4.5%+442.6%-35.4%+302.8%-593.4%at low
alltimeall time-4.5%+839.7%-35.4%+885.9%-4789.8%at low

BEAM Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$27.94M(-2.5%)
$112.74M(+1.1%)
Dec 2024
$111.53M(-4.5%)
$28.66M(+8.1%)
$111.53M(-11.6%)
Sep 2024
-
$26.52M(-10.5%)
$126.12M(+0.9%)
Jun 2024
-
$29.63M(+10.9%)
$125.02M(+4.1%)
Mar 2024
-
$26.72M(-38.2%)
$120.05M(+2.8%)
Dec 2023
$116.81M(+33.0%)
$43.26M(+70.2%)
$116.81M(+21.4%)
Sep 2023
-
$25.41M(+3.1%)
$96.24M(+3.9%)
Jun 2023
-
$24.66M(+5.0%)
$92.64M(+0.6%)
Mar 2023
-
$23.49M(+3.6%)
$92.05M(+4.8%)
Dec 2022
$87.81M(+53.4%)
$22.68M(+4.0%)
$87.81M(+5.9%)
Sep 2022
-
$21.82M(-9.3%)
$82.90M(+7.9%)
Jun 2022
-
$24.06M(+25.0%)
$76.86M(+16.1%)
Mar 2022
-
$19.25M(+8.3%)
$66.20M(+15.7%)
DateAnnualQuarterlyTTM
Dec 2021
$57.22M(+93.3%)
$17.77M(+12.7%)
$57.22M(+19.7%)
Sep 2021
-
$15.77M(+17.7%)
$47.80M(+20.9%)
Jun 2021
-
$13.40M(+30.5%)
$39.53M(+19.6%)
Mar 2021
-
$10.27M(+23.0%)
$33.07M(+11.7%)
Dec 2020
$29.61M(+44.0%)
$8.35M(+11.4%)
$29.61M(+8.0%)
Sep 2020
-
$7.50M(+8.1%)
$27.41M(+7.9%)
Jun 2020
-
$6.94M(+1.8%)
$25.40M(+8.4%)
Mar 2020
-
$6.81M(+10.6%)
$23.44M(+14.0%)
Dec 2019
$20.55M(+73.2%)
$6.16M(+12.3%)
$20.55M(+13.5%)
Sep 2019
-
$5.49M(+10.2%)
$18.10M(+17.2%)
Jun 2019
-
$4.98M(+26.7%)
$15.45M(+47.5%)
Mar 2019
-
$3.93M(+5.9%)
$10.47M(+60.0%)
Dec 2018
$11.87M
$3.71M(+30.9%)
$6.54M(+130.9%)
Sep 2018
-
$2.83M
$2.83M

FAQ

  • What is Beam Therapeutics annual SGA?
  • What is the all time high annual SGA for Beam Therapeutics?
  • What is Beam Therapeutics annual SGA year-on-year change?
  • What is Beam Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Beam Therapeutics?
  • What is Beam Therapeutics quarterly SGA year-on-year change?
  • What is Beam Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Beam Therapeutics?
  • What is Beam Therapeutics TTM SGA year-on-year change?

What is Beam Therapeutics annual SGA?

The current annual SGA of BEAM is $111.53M

What is the all time high annual SGA for Beam Therapeutics?

Beam Therapeutics all-time high annual SGA is $116.81M

What is Beam Therapeutics annual SGA year-on-year change?

Over the past year, BEAM annual SGA has changed by -$5.29M (-4.53%)

What is Beam Therapeutics quarterly SGA?

The current quarterly SGA of BEAM is $27.94M

What is the all time high quarterly SGA for Beam Therapeutics?

Beam Therapeutics all-time high quarterly SGA is $43.26M

What is Beam Therapeutics quarterly SGA year-on-year change?

Over the past year, BEAM quarterly SGA has changed by +$1.22M (+4.55%)

What is Beam Therapeutics TTM SGA?

The current TTM SGA of BEAM is -$6.10B

What is the all time high TTM SGA for Beam Therapeutics?

Beam Therapeutics all-time high TTM SGA is -$124.72M

What is Beam Therapeutics TTM SGA year-on-year change?

Over the past year, BEAM TTM SGA has changed by -$6.22B (-5180.03%)
On this page